Anbio Biotechnology (NNNN)
NASDAQ: NNNN · Real-Time Price · USD
20.93
-1.28 (-5.76%)
Mar 10, 2026, 4:00 PM EDT - Market closed
Anbio Biotechnology Market Cap
Anbio Biotechnology has a market cap or net worth of $918.64 million as of March 11, 2026. Its market cap has increased by 262.74% in one year.
Market Cap
918.64M
Enterprise Value
905.21M
1-Year Change
262.74%
Ranking
Category
Stock Price
$20.93
Market Cap Chart
Since the IPO on February 19, 2025, Anbio Biotechnology's market cap has increased from $219.46M to $918.64M, an increase of 318.60%. That is a compound annual growth rate of 291.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 974.82M | -26.14% |
| Dec 31, 2025 | 1.32B | 501.40% |
| Feb 19, 2025 | 219.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DENTSPLY SIRONA | 2.54B |
| LeMaitre Vascular | 2.45B |
| AtriCure | 1.50B |
| Kestra Medical Technologies | 1.34B |
| Pulse Biosciences | 1.23B |
| Azenta | 1.12B |
| BioLife Solutions | 959.24M |
| STAAR Surgical Company | 914.01M |